Editorial Board

51 Editors in 11 Countries/Region

Italy (18)
USA (13)
China (9)
Portugal (2)
Spain (2)
Germany (2)
United Kingdom (1)
Canada (1)
Switzerland (1)
Mexico (1)
South Korea (1)

Editor-in-Chief

Amedeo Lonardo

a.lonardo@libero.it

Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.

Research Interests: MAFLD, NAFLD, endocrine disorders, sex differences in NAFLD, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in HCV infection, diabetes in cirrhosis

Contributions:

Editorial: Metabolism and Target Organ Damage

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

The Fatty liver Index (FLI) 15 years later: a reappraisal

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Commentary: Of women, liver, and heart

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Is liver fibrosis a risk factor for gynecological cancers?

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Special Issue:

Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Honorary Editors-in-Chief

Christopher D. Byrne

Endocrinology & Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK.

Research Interests: liver lipid metabolism, endocrinology, dyslipidaemias, metabolic liver disease, type 2 diabetes, NAFLD

Contributions:

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Associate Editors

Luigi Elio Adinolfi

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Miraglia, Naples, Italy.

Research Interests: intrahepatic cholestasis, HCV cryoglobulinemia, chronic viral hepatitis, NAFLD, HCC

Pietro Andreone

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Research Interests: chronic hepatitis, cirrhosis, hepatocellular carcinoma, liver immunology, liver transplantation, liver stem cells

Contributions:

Liver transplantation and nonalcoholic steatohepatitis: the state of the art

Luigi Angrisani

Department of Public Health, School of Medicine and Surgery - “Federico II” University of Naples, Italy.

Research Interests: metabolic and Bariatric surgery - hiatal hernia, GERD and obesity - revisional surgery for weight regain and diabetes recurrence

Juan Pablo Arab

Department of Medicine, Division of Gastroenterology and Hepatology, Western University, Ontario, Canada.

Research Interests: nonalcoholic fatty liver disease, MAFLD, NAFLD, steatosis, fatty liver, alcohol, alcohol-associated liver disease

Contributions:

Sarcopenia in the setting of nonalcoholic fatty liver

Colorectal adenomas and MAFLD: a cross-sectional study in a Hispanic screening cohort

Gyorgy Baffy

Department of Medicine, VA Boston Healthcare System and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Research Interests: nonalcoholic fatty liver disease, metabolic dysfunction-associated liver disease, steatohepatitis, portal hypertension, cirrhosis

Contributions:

Mechanobiology in the development and progression of nonalcoholic fatty liver disease: an updated review

Special Issue:

Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Stefano Bellentani

Consultant Gastroenterologist and Hepatologist, Italian Liver Foundation, Basovizza, Italy.

Research Interests: NAFLD, NASH, epidemiology, chronic viral hepatitis, irritable bowel syndrome, inflammatory bowel disease, metabolic disease

Contributions:

The Fatty liver Index (FLI) 15 years later: a reappraisal

Helena Cortez-Pinto

Faculdade de Medicina de Lisboa, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.

Research Interests: NASH trials, metabolism, nutrition

Leonardo M. Fabbri

Department of Morphology, Surgery and Experimental Medicine, Section of Respiratory Diseases, University of Ferrara, Ferrara, Italy.

Research Interests: respiratory diseases, metabolic medicine, endocrinology geriatrics, metabolism

Silvia R. Fargion

Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Milan, Italy.

Research Interests: metabolic and virus liver diseases (MAFLD, NAFLD, HCV and HBV chronic hepatitis), vascular disorders in metabolic liver diseases, iron and copper induced liver diseases (hemochromatosis, Wilson disease)

Contributions:

Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system

Giampiero Francica

Interventional Ultrasound Unit, Pineta Grande Hospital, Castel Volturno, Italy.

Research Interests: ultrasound, diagnostic, biopsy and ablation of liver tumors

Special Issue:

Metabolism and Cancer

Fulvio Lonardo

Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.

Research Interests: morphological, molecular, epidemiological, thoracic malignancies

Contributions:

Metabolism and cancer-select topics

Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?

Luca Roncucci

Department of Maternal, Child and Adult Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: colorectal carcinogenesis, hereditary colorectal cancer, inflammation, chemoprevention of tumors

Contributions:

Colon cancer in a 12-year-old girl with hypertriglyceridemia

Special Issue:

Metabolism and Cancer

Ayako Suzuki

Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA.

Research Interests: NAFLD, NASH, biological disparities, sex differences, gender differences, drug-induced liver injury, hepatotoxicity

Contributions:

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Special Issue:

Sex Differences in Dysmetabolic Organ Damage and Senescence

Claudio Tiribelli

Fondazione Italiana Fegato-ONLUS, Trieste, Italy.

Research Interests: fatty liver and associated diseases, liver damage, stem cells in HCC, personalized treatment, NAFLD

Contributions:

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

The Fatty liver Index (FLI) 15 years later: a reappraisal

Wah Yang

Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.

Research Interests: metabolic and bariatric surgery, obesity, metabolic disorders

Special Issue:

Metabolic and Bariatric Surgery

Metabolic and Bariatric Surgery: Current Situation and Future Challenges

Clinical Advances in Bariatric Surgery: Current Trends, Outcomes, and Future Perspectives

Editorial Board Members

Annalisa Berzigotti

Swiss Liver Center, Visceral Surgery and Medicine Clinic (UVCM), Inselspital, University of Bern, Berne, Switzerland.

Research Interests: portal hypertension, non-invasive assessment of liver disease, obesity and liver disease

Stefano Bonapace

Section of Cardiology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.

Research Interests: heart failure, atrial fibrillation, atherosclerosis, diabetes, diastolic function

Fernando Bril

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Research Interests: insulin resistance, NAFLD, NASH, liver steatosis, fatty liver disease, lipotoxicity

Contributions:

Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients

Norberto Chavez-Tapia

Gastroenterology & Traslational Research Deparment, Medica Sur Clinic & Foundation, Mexico City, Mexico.

Research Interests: MASLD, liver cirrhosis, evidence based medicine

Weiyi Fang

Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, Guangdong, China.

Research Interests: tumor pharmacology, tumor pathogenesis, nanomaterial drug

Águeda González-Rodríguez

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), Madrid, Spain.

Research Interests: liver, metabolism, NAFLD, fibrosis, insulin resistance, hepatocytes

Contributions:

Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Giovanni Guaraldi

Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: HIV, immune-metabolism, NAFLF/MAFLD, lipodystrophy, aging, solid organ transplant, COVID-19

Youngmi Jung

Department of Biological Sciences, College of Natural Science, Pusan National University, Pusan, South Korea.

Research Interests: liver fibrosis, liver regeneration, stem cell therapy, cellular reprogramming, nonalcoholic fatty liver disease

Contributions:

Sex disparity in the liver regeneration focusing on sex hormones

Tatiana Y Kostrominova

Department of Anatomy and Cell Biology, Indiana University School of Medicine Northwest, Indianapolis, USA.

Research Interests: skeletal muscle, tendon, aging, denervation, obesity, myokines

Special Issue:

Skeletal Muscle Metabolism: Regulation, Adaptation, and Health

Annunziata Lapolla

Department of Medicine – DIMED, University of Padova, Padova, Italy.

Research Interests: diabetes, gestational diabetes, cardiovascular disease

George Lau

Department of Medicine, Humanity, and Health Medical Group, Hong Kong, China.
Liver Diseases & Transplant Centre, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

Research Interests: liver transplantation, liver failure, hepatocellular carcinoma

Ting Lei

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Research Interests: hypothalamic-pituitary disorders, brain tumor, molecular mechanism

Mariana Machado

Department of Gastroenterology and Hepatology, Hospital de Vila Franca de Xira, Lisbon, Portugal.

Research Interests: non-alcoholic/metabolic dysfunction-associated fatty liver disease, alcohol-associated liver disease, liver cirrhosis, end-stage liver disease, pathophysiology of liver disease

Contributions:

What should we advise MAFLD patients to eat and drink?

MAFLD under the lens: the role of gut microbiota

Special Issue:

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Alessandro Mantovani

Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Research Interests: NAFLD, cardiovascular disease, diabetes, ceramides, gender disparity in science

Contributions:

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

PNPLA3 rs738409 polymorphism and kidney dysfunction: an association beyond nonalcoholic fatty liver disease?

MariaLuz Martinez-Chantar

Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia, Spain.

Research Interests: liver disease, mechanism, metabolism, post-translational modifications, translational science

Chiara Mussi

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Civil Hospital, Modena, Italy.

Research Interests: lipid-lowering drugs, osteoporotic, cardiology, atrial fibrillation, dementia, older patients

Laura Nagy

Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH, USA.

Research Interests: alcohol-associated liver disease, macrophage biology, inflammation, cell death mechanisms, NAFLD/NASH

Contributions:

Diminished function of cytotoxic T- and NK- cells in severe alcohol-associated hepatitis

Sonia Najjar

Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Research Interests: insulin clearance, insulin metabolism, lipid metabolism, insulin resistance, inflammation, fibrosis, metabolic diseases, abdominal obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, atherosclerosis

Special Issue:

Altered Metabolism in Liver Injury

Natalia A Osna

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, USA.

Research Interests: alcohol-associated liver disease, hepatotropic viral infections, liver damage

Contributions:

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Zheng Ruan

State Key Laboratory of Food Science and Resources, Institute of Nutritional Sciences, Nanchang University, Nanchang, Jiangxi, China.

Research Interests: metabolism, nutrition, intestinal inflammation, fatty liver disease, anemia

David R Sinacore

Department of Physical Therapy, Congdon School of Health Sciences at High Point University, High Point, NC, USA.

Research Interests: obesity, diabetes mellitus, peripheral neuropathy, physical frailty, sarcopenia, osteoporosis and chronic kidney disease

Contributions:

Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy

Ashwani K Singal

Department of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.

Research Interests: nonalcoholic fatty liver disease, liver transplantation, alcoholic hepatitis

Contributions:

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Special Issue:

Liver Transplantation for Alcohol and Metabolic Associated Steatotic Liver Disease

Norbert Stefan

Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, Tubingen, Germany.

Research Interests: pathophysiology of obesity and type 2 diabetes, pathophysiology and consequences of NAFLD, metabolically healthy obesity, hepatokines

Contributions:

Screening for advanced liver fibrosis in overweight and obese patients with NAFLD

Saula Vigili de Kreutzenberg

Department of Medicine, Division of Metabolic Diseases, University of Padova, Padova, Italy.

Research Interests: cardiovascular, NAFLD, type 2 diebetes, endocrinology, metabolic diseases

Ralf Weiskirchen

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany.

Research Interests: TGF-beta, PDGF, liver, fibrosis, extracellular matrix

Contributions:

The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis

Diabetes mellitus and heart disease

Special Issue:

Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Vincent Wai Sun Wong

Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Research Interests: MASLD, viral hepatitis, liver fibrosis

Xingjiang Xiong

Department of Cardiology, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Research Interests: hypertension, cardiovascular disease, critical care medicine, traditional chinese medicine, classic herbal formula

Haoyong Yu

Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital, affiliated to Shanghai Jiao Tong University, Shanghai, China.

Research Interests: diabetes, obesity, metabolic surgery

Kezhong Zhang

Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA.

Research Interests: organelle stress response, cell metabolism, inflammation

Minghua Zheng

MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Research Interests: MASH, liver cirrhosis, liver fibrosis

Contributions:

Are hepatocytes endocrine cells?

Perspective of tumor heterogeneity for treatments of intrahepatic cholangiocarcinoma with intrahepatic lithiasis

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Huiping Zhou

Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA.

Research Interests: bile acids, sphingolipids, metabolic and liver diseases, liver cancer

Jinrong Zhou

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Research Interests: nutrition, diet, metabolic disorders, cancer prevention

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/